COR - Drug Wholesale Firm Cencora Starts 2024 With Strong Growth Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution | Benzinga
Cencora Inc’s (NYSE:COR), formerly AmerisourceBergen Corporation, first quarter 2024 adjusted EPS reached $3.28, up from $2.71 Y/Y, beating the consensus of $2.89.
In the first quarter, revenue was $72.3 billion, up 15% Y/Y, beating the consensus of $69.17 billion, reflecting a 15.9% increase in revenue within U.S. Healthcare Solutions and a 6.9% increase in revenue within International Healthcare Solutions.
The adjusted gross profit margin was 3.31%, a decrease of 7 basis points from the prior-year ...